Two pneumonia vaccinations are available. The newest one, Prevnar 13, stimulates higher antibody levels. Research is under way to find out if the new vaccine works better. Everyone over 65 or at risk of pneumonia complications should be vaccinated.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.